MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway

Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis

(2014) Zhi Peng et al.   PLoS One

MicroRNA-206 suppresses gastric cancer cell growth and metastasis

(2014) Jun Ren et al.   Cell and Bioscience

A systematic review of microRNA expression profiling studies in human gastric cancer

(2014) Sirjana Shrestha et al.   Cancer Medicine

MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2

(2013) Lin Zhang et al.   CANCER LETTERS

Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis

(2013) Zongyue Zeng et al.   PLoS One

The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays

(2012) Kambiz Sotoudeh et al.   Diagnostic Pathology

Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth

(2012) Xiao-Pu He et al.   FEBS Journal

A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis

(2012) Mansi A Parasramka et al.   Clinical Epigenetics

Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer

(2011) H.-K. Oh et al.   CLINICAL CANCER RESEARCH

MicroRNA-1/206 Targets c-Metand Inhibits Rhabdomyosarcoma Development

(2009) Dongsheng Yan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

(2009) Tetsuya Ueda et al.   LANCET ONCOLOGY